CA3076993A1 — Intranasal delivery devices
Assigned to Shin Nippon Biomedical Laboratories Ltd · Expires 2019-04-04 · 7y expired
What this patent protects
The present disclosure provides devices for delivery of powder formulations and methods of manufacture and use of such devices, wherein the device comprises, a nozzle having a reservoir disposed within the nozzle, a valve at least partially fit into the reservoir, a retainer that…
USPTO Abstract
The present disclosure provides devices for delivery of powder formulations and methods of manufacture and use of such devices, wherein the device comprises, a nozzle having a reservoir disposed within the nozzle, a valve at least partially fit into the reservoir, a retainer that is hollow and holds the valve, and a manual air pump operably linked to an upstream end of the nozzle and a downstream end of the retainer, wherein the valve has one or more contacting points with the retainer, and when the manual air pump is activated, said valve is lifted by the retainer and contacts the nozzle.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.